Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis
- PMID: 19430123
- DOI: 10.1007/s12038-009-0013-7
Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis
Abstract
Human papillomavirus (HPV) is small, double-stranded DNA virus that infects mucosal and cutaneous epithelial tissue. HPV is sexually transmitted and the viral DNA replicates extrachromosomally. The virus is non-enveloped and has an icosahedral capsid. There are approximately 118 types of HPV, which are characterized as high-risk or low- risk types. High-risk HPVs cause malignant transformation while the low-risk ones cause benign warts and lesions. The expression of E6 and E7 is normally controlled during the normal viral life cycle when viral DNA replicates extrachromosomally. HPV E6 and E7 oncoproteins are overexpressed when the viral genome integrates into the host DNA.Deregulated overexpression of E6 and E7 oncoproteins can cause several changes in cellular pathways and functions leading to malignant transformation of cells and tumorigenesis. In this review, we focus on several cellular mechanisms and pathways that are altered in the presence of E6 and E7, the target proteins of E6 and E7 inside the host cell and how they contribute to the development of the transformed phenotype.
Similar articles
-
High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.J Virol. 2017 Sep 27;91(20):e01084-17. doi: 10.1128/JVI.01084-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28768872 Free PMC article.
-
Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins.mSphere. 2020 Jul 15;5(4):e00398-20. doi: 10.1128/mSphere.00398-20. mSphere. 2020. PMID: 32669468 Free PMC article.
-
The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.J Gen Virol. 2021 Mar;102(3):001540. doi: 10.1099/jgv.0.001540. Epub 2021 Jan 11. J Gen Virol. 2021. PMID: 33427604 Free PMC article. Review.
-
Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.Cell Oncol (Dordr). 2012 Apr;35(2):67-76. doi: 10.1007/s13402-011-0069-x. Epub 2012 Jan 20. Cell Oncol (Dordr). 2012. PMID: 22262402 Review.
-
Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease.Viruses. 2022 Sep 28;14(10):2138. doi: 10.3390/v14102138. Viruses. 2022. PMID: 36298698 Free PMC article. Review.
Cited by
-
Gold-Hybridized Zinc Oxide Nanorods as Real-Time Low-Cost NanoBiosensors for Detection of virulent DNA signature of HPV-16 in Cervical Carcinoma.Sci Rep. 2019 Nov 19;9(1):17039. doi: 10.1038/s41598-019-53476-9. Sci Rep. 2019. PMID: 31745139 Free PMC article.
-
The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers.Asian Pac J Cancer Prev. 2023 Sep 1;24(9):3139-3153. doi: 10.31557/APJCP.2023.24.9.3139. Asian Pac J Cancer Prev. 2023. PMID: 37774066 Free PMC article. Review.
-
IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).Oncol Rep. 2014 Dec;32(6):2295-306. doi: 10.3892/or.2014.3505. Epub 2014 Sep 19. Oncol Rep. 2014. PMID: 25333772 Free PMC article. Review.
-
Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer.Oncol Lett. 2018 Jan;15(1):11-22. doi: 10.3892/ol.2017.7292. Epub 2017 Oct 30. Oncol Lett. 2018. PMID: 29285184 Free PMC article.
-
E6/E7 Sequence Diversity of High-Risk Human Papillomaviruses in Two Geographically Isolated Populations of French Guiana.Microorganisms. 2020 Nov 23;8(11):1842. doi: 10.3390/microorganisms8111842. Microorganisms. 2020. PMID: 33238632 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources